Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Exercise induces region-specific remodeling of astrocyte morphology and reactive astrocyte gene expression patterns in male mice.

Lundquist AJ, Parizher J, Petzinger GM, Jakowec MW.

J Neurosci Res. 2019 Jun 7. doi: 10.1002/jnr.24430. [Epub ahead of print]

PMID:
31175682
2.

Intensive treadmill exercise increases expression of hypoxia-inducible factor 1α and its downstream transcript targets: a potential role in neuroplasticity.

Halliday MR, Abeydeera D, Lundquist AJ, Petzinger GM, Jakowec MW.

Neuroreport. 2019 Jun 12;30(9):619-627. doi: 10.1097/WNR.0000000000001239.

PMID:
31045849
3.

Worse cognitive performance predicts increased anxiety and depressive symptoms in patients with Parkinson's disease: A bidirectional analysis.

Petkus AJ, Filoteo JV, Schiehser DM, Gomez ME, Petzinger G.

Neuropsychology. 2019 Jan;33(1):35-46. doi: 10.1037/neu0000498. Epub 2018 Oct 18.

PMID:
30335414
4.

Basal ganglia and beyond: The interplay between motor and cognitive aspects in Parkinson's disease rehabilitation.

Ferrazzoli D, Ortelli P, Madeo G, Giladi N, Petzinger GM, Frazzitta G.

Neurosci Biobehav Rev. 2018 Jul;90:294-308. doi: 10.1016/j.neubiorev.2018.05.007. Epub 2018 May 4. Review.

5.

The Oxygen Paradox, the French Paradox, and age-related diseases.

Davies JMS, Cillard J, Friguet B, Cadenas E, Cadet J, Cayce R, Fishmann A, Liao D, Bulteau AL, Derbré F, Rébillard A, Burstein S, Hirsch E, Kloner RA, Jakowec M, Petzinger G, Sauce D, Sennlaub F, Limon I, Ursini F, Maiorino M, Economides C, Pike CJ, Cohen P, Salvayre AN, Halliday MR, Lundquist AJ, Jakowec NA, Mechta-Grigoriou F, Mericskay M, Mariani J, Li Z, Huang D, Grant E, Forman HJ, Finch CE, Sun PY, Pomatto LCD, Agbulut O, Warburton D, Neri C, Rouis M, Cillard P, Capeau J, Rosenbaum J, Davies KJA.

Geroscience. 2017 Dec;39(5-6):499-550. doi: 10.1007/s11357-017-0002-y. Epub 2017 Dec 21. Review.

6.
7.

Treadmill exercise delays the onset of non-motor behaviors and striatal pathology in the CAG140 knock-in mouse model of Huntington's disease.

Stefanko DP, Shah VD, Yamasaki WK, Petzinger GM, Jakowec MW.

Neurobiol Dis. 2017 Sep;105:15-32. doi: 10.1016/j.nbd.2017.05.004. Epub 2017 May 11.

PMID:
28502806
8.

Engaging cognitive circuits to promote motor recovery in degenerative disorders. exercise as a learning modality.

Jakowec MW, Wang Z, Holschneider D, Beeler J, Petzinger GM.

J Hum Kinet. 2016 Sep 10;52:35-51. doi: 10.1515/hukin-2015-0192. eCollection 2016 Sep 1.

9.

Noradrenergic mechanisms of arousal's bidirectional effects on episodic memory.

Clewett D, Sakaki M, Nielsen S, Petzinger G, Mather M.

Neurobiol Learn Mem. 2017 Jan;137:1-14. doi: 10.1016/j.nlm.2016.10.017. Epub 2016 Nov 2.

10.

Evidence of functional brain reorganization on the basis of blood flow changes in the CAG140 knock-in mouse model of Huntington's disease.

Wang Z, Stefanko DP, Guo Y, Toy WA, Petzinger GM, Jakowec MW, Holschneider DP.

Neuroreport. 2016 Jun 15;27(9):632-9. doi: 10.1097/WNR.0000000000000587.

PMID:
27082842
11.

The Effects of Exercise on Dopamine Neurotransmission in Parkinson's Disease: Targeting Neuroplasticity to Modulate Basal Ganglia Circuitry.

Petzinger GM, Holschneider DP, Fisher BE, McEwen S, Kintz N, Halliday M, Toy W, Walsh JW, Beeler J, Jakowec MW.

Brain Plast. 2015;1(1):29-39.

12.

Context-Dependent Learning in People With Parkinson's Disease.

Lee YY, Winstein CJ, Gordon J, Petzinger GM, Zelinski EM, Fisher BE.

J Mot Behav. 2016 May-Jun;48(3):240-8. doi: 10.1080/00222895.2015.1082964. Epub 2015 Sep 16.

PMID:
26375786
13.

Personality traits and the risk for Parkinson disease: a prospective study.

Sieurin J, Gustavsson P, Weibull CE, Feldman AL, Petzinger GM, Gatz M, Pedersen NL, Wirdefeldt K.

Eur J Epidemiol. 2016 Feb;31(2):169-75. doi: 10.1007/s10654-015-0062-1. Epub 2015 Jul 1.

14.

A kinder, gentler dopamine… highlighting dopamine's role in behavioral flexibility.

Beeler JA, Cools R, Luciana M, Ostlund SB, Petzinger G.

Front Neurosci. 2014 Jan 24;8:4. doi: 10.3389/fnins.2014.00004. eCollection 2014. No abstract available.

15.

Treadmill exercise reverses dendritic spine loss in direct and indirect striatal medium spiny neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.

Toy WA, Petzinger GM, Leyshon BJ, Akopian GK, Walsh JP, Hoffman MV, Vučković MG, Jakowec MW.

Neurobiol Dis. 2014 Mar;63:201-9. doi: 10.1016/j.nbd.2013.11.017. Epub 2013 Dec 5.

16.

The Enemy within: Propagation of Aberrant Corticostriatal Learning to Cortical Function in Parkinson's Disease.

Beeler JA, Petzinger G, Jakowec MW.

Front Neurol. 2013 Sep 12;4:134. doi: 10.3389/fneur.2013.00134. eCollection 2013. Review.

17.

Exercise modifies α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor expression in striatopallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse.

Kintz N, Petzinger GM, Akopian G, Ptasnik S, Williams C, Jakowec MW, Walsh JP.

J Neurosci Res. 2013 Nov;91(11):1492-507. doi: 10.1002/jnr.23260. Epub 2013 Aug 6.

PMID:
23918451
18.

Exercise-enhanced neuroplasticity targeting motor and cognitive circuitry in Parkinson's disease.

Petzinger GM, Fisher BE, McEwen S, Beeler JA, Walsh JP, Jakowec MW.

Lancet Neurol. 2013 Jul;12(7):716-26. doi: 10.1016/S1474-4422(13)70123-6.

19.

Treadmill exercise elevates striatal dopamine D2 receptor binding potential in patients with early Parkinson's disease.

Fisher BE, Li Q, Nacca A, Salem GJ, Song J, Yip J, Hui JS, Jakowec MW, Petzinger GM.

Neuroreport. 2013 Jul 10;24(10):509-14. doi: 10.1097/WNR.0b013e328361dc13.

PMID:
23636255
20.

Brief mitochondrial inhibition causes lasting changes in motor behavior and corticostriatal synaptic physiology in the Fischer 344 rat.

Akopian G, Crawford C, Petzinger G, Jakowec MW, Walsh JP.

Neuroscience. 2012 Jul 26;215:149-59. doi: 10.1016/j.neuroscience.2012.04.060. Epub 2012 Apr 30.

21.

Accuracy and sensitivity of Parkinsonian disorder diagnoses in two Swedish national health registers.

Feldman AL, Johansson AL, Gatz M, Flensburg M, Petzinger GM, Widner H, Lew MF, Pedersen NL, Wirdefeldt K.

Neuroepidemiology. 2012;38(3):186-93. doi: 10.1159/000336356. Epub 2012 Mar 29.

22.

MPTP Neurotoxicity and Testosterone Induce Dendritic Remodeling of Striatal Medium Spiny Neurons in the C57Bl/6 Mouse.

Antzoulatos E, Jakowec MW, Petzinger GM, Wood RI.

Parkinsons Dis. 2011;2011:138471. doi: 10.4061/2011/138471. Epub 2011 Jun 8.

23.

How might physical activity benefit patients with Parkinson disease?

Speelman AD, van de Warrenburg BP, van Nimwegen M, Petzinger GM, Munneke M, Bloem BR.

Nat Rev Neurol. 2011 Jul 12;7(9):528-34. doi: 10.1038/nrneurol.2011.107. Review.

PMID:
21750523
24.

The role of exercise in facilitating basal ganglia function in Parkinson's disease.

Petzinger GM, Fisher BE, Akopian G, Holschneider DP, Wood R, Walsh JP, Lund B, Meshul C, Vuckovic M, Jakowec MW.

Neurodegener Dis Manag. 2011 Apr 1;1(2):157-170.

25.

Exercise elevates dopamine D2 receptor in a mouse model of Parkinson's disease: in vivo imaging with [¹⁸F]fallypride.

Vučković MG, Li Q, Fisher B, Nacca A, Leahy RM, Walsh JP, Mukherjee J, Williams C, Jakowec MW, Petzinger GM.

Mov Disord. 2010 Dec 15;25(16):2777-84. doi: 10.1002/mds.23407.

26.

Acute and long-term response of dopamine nigrostriatal synapses to a single, low-dose episode of 3-nitropropionic acid-mediated chemical hypoxia.

Crawford CA, Akopian G, Ring J, Jakowec MW, Petzinger GM, Andersen JK, Vittozzi-Wong P, Wang K, Farley CM, Charntikov S, Mitroi D, Beal MF, Chow R, Walsh JP.

Synapse. 2011 Apr;65(4):339-50. doi: 10.1002/syn.20852. Epub 2010 Oct 8.

27.

Exercise effects on motor and affective behavior and catecholamine neurochemistry in the MPTP-lesioned mouse.

Gorton LM, Vuckovic MG, Vertelkina N, Petzinger GM, Jakowec MW, Wood RI.

Behav Brain Res. 2010 Dec 1;213(2):253-62. doi: 10.1016/j.bbr.2010.05.009. Epub 2010 May 21.

28.

Sex differences in motor behavior in the MPTP mouse model of Parkinson's disease.

Antzoulatos E, Jakowec MW, Petzinger GM, Wood RI.

Pharmacol Biochem Behav. 2010 Jun;95(4):466-72. doi: 10.1016/j.pbb.2010.03.009. Epub 2010 Mar 27.

29.

Enhancing neuroplasticity in the basal ganglia: the role of exercise in Parkinson's disease.

Petzinger GM, Fisher BE, Van Leeuwen JE, Vukovic M, Akopian G, Meshul CK, Holschneider DP, Nacca A, Walsh JP, Jakowec MW.

Mov Disord. 2010;25 Suppl 1:S141-5. doi: 10.1002/mds.22782.

30.

Altered AMPA receptor expression with treadmill exercise in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury.

VanLeeuwen JE, Petzinger GM, Walsh JP, Akopian GK, Vuckovic M, Jakowec MW.

J Neurosci Res. 2010 Feb 15;88(3):650-68. doi: 10.1002/jnr.22216.

PMID:
19746427
31.

The relationships between the unified Parkinson's disease rating scale and lower extremity functional performance in persons with early-stage Parkinson's disease.

Song J, Fisher BE, Petzinger G, Wu A, Gordon J, Salem GJ.

Neurorehabil Neural Repair. 2009 Sep;23(7):657-61. doi: 10.1177/1545968309332878. Epub 2009 Mar 31.

PMID:
19336530
32.

Decreased striatal dopamine release underlies increased expression of long-term synaptic potentiation at corticostriatal synapses 24 h after 3-nitropropionic-acid-induced chemical hypoxia.

Akopian G, Crawford C, Beal MF, Cappelletti M, Jakowec MW, Petzinger GM, Zheng L, Gheorghe SL, Reichel CM, Chow R, Walsh JP.

J Neurosci. 2008 Sep 17;28(38):9585-97. doi: 10.1523/JNEUROSCI.5698-07.2008.

33.

Memory, mood, dopamine, and serotonin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury.

Vucković MG, Wood RI, Holschneider DP, Abernathy A, Togasaki DM, Smith A, Petzinger GM, Jakowec MW.

Neurobiol Dis. 2008 Nov;32(2):319-27. doi: 10.1016/j.nbd.2008.07.015. Epub 2008 Aug 5.

34.

The effect of exercise training in improving motor performance and corticomotor excitability in people with early Parkinson's disease.

Fisher BE, Wu AD, Salem GJ, Song J, Lin CH, Yip J, Cen S, Gordon J, Jakowec M, Petzinger G.

Arch Phys Med Rehabil. 2008 Jul;89(7):1221-9. doi: 10.1016/j.apmr.2008.01.013. Epub 2008 Jun 13.

35.

Complete ascertainment of Parkinson disease in the Swedish Twin Registry.

Wirdefeldt K, Gatz M, Bakaysa SL, Fiske A, Flensburg M, Petzinger GM, Widner H, Lew MF, Welsh M, Pedersen NL.

Neurobiol Aging. 2008 Dec;29(12):1765-73. Epub 2007 May 29.

36.

Asymmetric corticomotor excitability correlations in early Parkinson's disease.

Wu AD, Petzinger GM, Lin CH, Kung M, Fisher B.

Mov Disord. 2007 Aug 15;22(11):1587-93.

PMID:
17523196
37.

Effects of treadmill exercise on dopaminergic transmission in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury.

Petzinger GM, Walsh JP, Akopian G, Hogg E, Abernathy A, Arevalo P, Turnquist P, Vucković M, Fisher BE, Togasaki DM, Jakowec MW.

J Neurosci. 2007 May 16;27(20):5291-300.

39.

High and low responders to novelty show differential effects in striatal glutamate.

Shakil SS, Holmer HK, Moore C, Abernathy AT, Jakowec MW, Petzinger GM, Meshul CK.

Synapse. 2005 Dec 1;58(3):200-7.

PMID:
16138315
40.
41.

Exercise-induced behavioral recovery and neuroplasticity in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse basal ganglia.

Fisher BE, Petzinger GM, Nixon K, Hogg E, Bremmer S, Meshul CK, Jakowec MW.

J Neurosci Res. 2004 Aug 1;77(3):378-90.

PMID:
15248294
42.
43.
44.

Human neural stem cell transplantation in the MPTP-lesioned mouse.

Liker MA, Petzinger GM, Nixon K, McNeill T, Jakowec MW.

Brain Res. 2003 May 9;971(2):168-77.

PMID:
12706233
45.

Absence of elevated anti-alpha-synuclein and anti-EBV latent membrane protein antibodies in PD.

Woulfe JM, Duke R, Middeldorp JM, Stevens S, Vervoort M, Hashimoto M, Masliah E, Chan P, Di Monte DA, Langston JW, Petzinger G, Hoogendoorn H, Munoz DG.

Neurology. 2002 May 14;58(9):1435-6. No abstract available.

PMID:
12011302
47.

Postnatal expression of alpha-synuclein protein in the rodent substantia nigra and striatum.

Jakowec MW, Donaldson DM, Barba J, Petzinger GM.

Dev Neurosci. 2001;23(2):91-9.

PMID:
11509831
48.

Reliability and validity of a new global dyskinesia rating scale in the MPTP-lesioned non-human primate.

Petzinger GM, Quik M, Ivashina E, Jakowec MW, Jakubiak M, Di Monte D, Langston JW.

Mov Disord. 2001 Mar;16(2):202-7. Review.

PMID:
11295771
49.

The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety.

Przedborski S, Jackson-Lewis V, Naini AB, Jakowec M, Petzinger G, Miller R, Akram M.

J Neurochem. 2001 Mar;76(5):1265-74. Review. No abstract available.

50.

Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model.

Di Monte DA, McCormack A, Petzinger G, Janson AM, Quik M, Langston WJ.

Mov Disord. 2000 May;15(3):459-66.

PMID:
10830409

Supplemental Content

Loading ...
Support Center